Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Range Cancer Therapeutics Index (CNCR)

Range Cancer Therapeutics Index (CNCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Range ETFs
  • Assets Under Management 11,138,600
  • Shares Outstanding, K 830
  • 60-Month Beta 0.90
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend 1.853 on 12/29/21
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.20 +1.67%
on 11/19/24
15.94 -15.81%
on 11/11/24
-1.94 (-12.62%)
since 10/18/24
3-Month
13.20 +1.67%
on 11/19/24
16.27 -17.52%
on 09/16/24
-1.35 (-9.14%)
since 08/20/24
52-Week
10.30 +30.29%
on 11/21/23
17.96 -25.28%
on 03/01/24
+2.77 (+26.01%)
since 11/20/23

Most Recent Stories

More News
4 Solid ETFs Under $20 for Your Portfolio

Most investors want to invest in equities but may be unable to afford large stakes in valuable companies with higher-priced stocks. Lower-priced stocks could be attractive for them as they enable them...

DIV : 18.81 (+0.21%)
SFYX : 15.06 (+0.40%)
CNCR : 13.42 (-0.07%)
FXN : 17.73 (+1.37%)
5 ETFs That Led the Rebound on Monday

Wall Street recovered from its biggest weekly losses of the year on Monday, driven by bargain hunting and looming Fed rate cuts. The S&P 500, Nasdaq Composite Index and the Dow Jones Industrial Average...

CNCR : 13.42 (-0.07%)
MSOS : 4.76 (+1.71%)
DAPP : 18.17 (+0.33%)
WGMI : 26.46 (-0.19%)
AUMI : 37.18 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Fund Summary

The Range Cancer Therapeutics ETF seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Range Cancer Therapeutics Index.

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point 13.71
2nd Resistance Point 13.59
1st Resistance Point 13.50
Last Price 13.42
1st Support Level 13.29
2nd Support Level 13.17
3rd Support Level 13.08

See More

52-Week High 17.96
Fibonacci 61.8% 15.03
Fibonacci 50% 14.13
Last Price 13.42
Fibonacci 38.2% 13.23
52-Week Low 10.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar